date,title,source
Oct-17-18,"Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-22-18,Adaptimmune's stock tumbles after cancer study results prompts price target cut,MarketWatch
Oct-25-18,"Adaptimmune to Report Third Quarter 2018 Financial Results and Business Update on Tuesday, November 6, 2018",GlobeNewswire
Oct-25-18,3 Beaten-Down Biotech Stocks: Can They Bounce Back?,Motley Fool
Oct-25-18,Adaptimmune Therapeutics Worldwide Enters Oversold Territory,Zacks
